Edwards Lifesciences EW Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Edwards Lifesciences in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edwards Lifesciences's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edwards Lifesciences's accounts payable?
- Edwards Lifesciences (EW) reported accounts payable of $181.1M in Q1 2026.
- How has Edwards Lifesciences's accounts payable changed year-over-year?
- Edwards Lifesciences's accounts payable increased by 5.0% year-over-year, from $172.4M to $181.1M.
- What is the long-term trend for Edwards Lifesciences's accounts payable?
- Over 5 years (2020 to 2025), Edwards Lifesciences's accounts payable has grown at a 3.0% compound annual growth rate (CAGR), from $196.5M to $227.5M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.